We are building medtech

GE HealthCare, which has its largest R&D centre located in Bengaluru—employing 2,000+ engineers and holding over 1,250 patents—is heavily invested in AI, using it to enhance medical imaging quality, improve workflow efficiency, and support clinical decision-making.

- 

While the company plans to invest ₹8,000 crore by 2029 in manufacturing and local R&D, its partnerships with institutes like AIIMS, Indian Institute of Science and Tata Memorial Centre, reflect a focused strategy to co-create scalable solutions that meet the country's diverse healthcare needs.

Girish Raghavan, CTO – Women's Health & X-Ray and VP, Engineering at GE HealthCare Technology Centre India, speaks to Sudhir Chowdhary on the company's tech priorities and key trends in the healthcare industry. Excerpts:

What are the current expansion plans when it comes to capacity?

The MedTech sector is called the 'Sunrise sector' for a reason—it is poised for exponential growth, with projections indicating India's global market share could rise from 1.65% to 10–12% over the next 25 years.

This trajectory is backed by rising public health expenditure and an increasing push for self-reliance in MedTech manufacturing.

India is at the forefront of becoming a MedTech hub, leading innovation and investment in healthcare.

Wipro GE Healthcare is among the first MedTech companies to 'Make in India—for India and the world.